Abstract Details

Title Sample Size Estimations for MRI-Monitored Trials of MS Considering Reduction in Formation of New Black Holes as Primary Endpoint

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 127

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
David J. Fink, MD, FAAN (University of Michigan)	No disclosure on file
	No disclosure on file
Ceyla Irkec, MD (Gazi University Hospital)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ��